OTLC today
$0.04+$0.00 (+3.26%)close Jun 25, 2026Trend
—
Key levels
—
Latest news & SEC filings
SEC FilingOncotelic Therapeutics, Inc. filed an insider trading report (Form 4)
All OTLC news →OTC · Healthcare
Oncotelic Therapeutics, Inc. (OTLC)
What Is the Price Target for OTLC?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is OTLC a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for OTLC.
Start Free Trial →Is OTLC Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B
Fair Value
$0.04
5
Moat Score
NONE
3/9
Piotroski Score
-2.3
Altman Z-Score
What Is Smart Money Doing with OTLC?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Trieu Vuong | director officer 10% owner | Buy | 1,044,990 | $18K | Oct 29, 2026 |
| Trieu Vuong | director officer 10% owner | Buy | 312,000 | $6K | Oct 28, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →OTLC Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
6000%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Oncotelic Therapeutics, Inc. (OTLC) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →OTLC — frequently asked questions
What is OTLC stock price today?
Oncotelic Therapeutics, Inc. (OTLC) is at $0.04, up 3.26% (+$0.00) at the Jun 25, 2026 close.
Why is OTLC stock moving today?
Latest OTLC news — Oct 30, 2026: Oncotelic Therapeutics, Inc. filed an insider trading report (Form 4)
Did OTLC beat earnings?
OTLC last reported on Aug 13, 2026: EPS $0.00 vs -$0.02 expected — a beat of 104.5%.
Does OTLC pay a dividend?
OTLC does not currently pay a dividend.
What are insiders doing with OTLC?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on OTLC?
Oct 30, 2026: Oncotelic Therapeutics, Inc. filed an insider trading report (Form 4)